InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (32 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
32
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Brainard Diana, Chairman & CEO. Officer active across 2 companies, notably Allovir, Inc.. Aggregated, 39 filings have been recorded. Breakdown: 0 buy · 32 sells. Total volume traded: €618k. Activity tracked since 17 May 2021. The latest transaction was filed on 19 November 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Brainard Diana
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
8,706 shares@ US$0.54850.7% of flowCommon StockSEC:0000950170-24-129257:0
10,609 shares@ US$0.86491.4% of flowCommon StockSEC:0000950170-24-122336:0
9,752 shares@ US$0.7791.1% of flowCommon StockSEC:0000950170-24-116645:0
1,493 shares@ US$0.81480.2% of flowCommon StockSEC:0000950170-24-112912:0
5,390 shares@ US$0.74130.6% of flowCommon StockSEC:0000950170-24-099846:0
3,091 shares@ US$0.75950.3% of flowCommon StockSEC:0000950170-24-099102:0
10,847 shares@ US$0.73481.2% of flowCommon StockSEC:0000950170-24-092807:0
9,731 shares@ US$0.75011.1% of flowCommon StockSEC:0000950170-24-085669:0
1,489 shares@ US$0.720.2% of flowCommon StockSEC:0000950170-24-081511:0
5,149 shares@ US$0.79230.6% of flowCommon StockSEC:0000950170-24-064052:0
3,075 shares@ US$0.74930.3% of flowCommon StockSEC:0000950170-24-062982:0
10,240 shares@ US$0.7961.2% of flowCommon StockSEC:0000950170-24-054512:0
9,601 shares@ US$0.75061.1% of flowCommon StockSEC:0000950170-24-046908:0
1,533 shares@ US$0.7720.2% of flowCommon StockSEC:0000950170-24-041810:0
3,097 shares@ US$0.69520.3% of flowCommon StockSEC:0000950170-24-018785:0
41,421 shares@ US$0.674.2% of flowCommon StockSEC:0000950170-24-011769:0
9,500 shares@ US$0.67040.9% of flowCommon StockSEC:0000950170-24-007406:0
1,664 shares@ US$0.6390.2% of flowCommon StockSEC:0000950170-24-002935:0
2,689 shares@ US$1.63110.7% of flowCommon StockSEC:0001209191-23-056313:0
4,382 shares@ US$1.69051.1% of flowCommon StockSEC:0001209191-23-056313:1
8,581 shares@ US$1.582.1% of flowCommon StockSEC:0001209191-23-053349:0
1,325 shares@ US$1.97630.4% of flowCommon StockSEC:0001209191-23-052229:0
11,361 shares@ US$2.49554.2% of flowCommon StockSEC:0001209191-23-046732:0
8,342 shares@ US$3.56154.3% of flowCommon StockSEC:0001209191-23-043121:0
5,275 shares@ US$3.04512.4% of flowCommon StockSEC:0001209191-23-041583:0
25 of 39 declarations
About Brainard Diana
Brainard Diana is President and Chief Executive Officer. She has filed 39 disclosures in total, all within the tracked sample, with sell transactions for EUR 618425 and no purchases, over the period from 2021-05-18 to 2024-11-20. The main recent sales concern Allovir, Inc., including EUR 161930.8879197554 on 2023-01-23, EUR 120557.2952107774 on 2022-05-23, and EUR 35112.84380098255 on 2022-08-19.
